[Definition of phases for research on drugs in man].
作者信息
Rahn K H
出版信息
Arzneimittelforschung. 1973 Nov;23(11):Suppl:1618-9.
PMID:4592632
Abstract
摘要
相似文献
1
[Definition of phases for research on drugs in man].
Arzneimittelforschung. 1973 Nov;23(11):Suppl:1618-9.
2
"Getting the dose right": facts, a blueprint, and encouragements.“精准给药”：事实、蓝图与鼓励
Clin Pharmacol Ther. 2007 Jul;82(1):12-4. doi: 10.1038/sj.clpt.6100215.
3
General considerations for studies of the metabolism of drugs and other chemicals.药物及其他化学物质代谢研究的一般考量因素。
Drug Metab Rev. 1982;13(6):929-39. doi: 10.3109/03602538208991370.
4
Drug efficacy--double-blind studies.
J Rehabil. 1974 Sep-Oct;40(5):26-30.
5
When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.药物研发过程中何时开展肾功能损害研究：美国食品药品监督管理局的观点
Clin Pharmacol Ther. 2009 Nov;86(5):475-9. doi: 10.1038/clpt.2009.190.
6
Clinical investigation of new drugs.新药的临床研究
N Engl J Med. 1967 Nov 23;277(21):1148-9. doi: 10.1056/NEJM196711232772114.
7
Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group.
World Health Organ Tech Rep Ser. 1975(563):1-59.
8
[Research in the field of clinical pharmacology in the USSR].[苏联临床药理学领域的研究]
Farmakol Toksikol. 1982 May-Jun;45(3):5-12.
9
FDA's biomedical research program.美国食品药品监督管理局的生物医学研究项目。
J Parenter Drug Assoc. 1980 Mar-Apr;34(2):134-8.
10
Initial human trials with an investigational new drug (phase I and 2): planning an management.新型研究药物的首次人体试验（I期和II期）：规划与管理
J Postgrad Med. 1981 Oct;27(4):197-213.
Zotero 插件